Wayne State University

Aim Higher

School of Medicine

Interventional Cardiology

Contact Information:

311 Mack Ave.
Detroit, MI 48201
Phone: (313) 577-6226
Fax: (313) 745-4707

Theodore L. Schreiber, M.D., F.A.C.C., F.A.S.C.I., F.A.C.P
Fellowship Director

Venicia Foreman
Phone: (313) 832-0303
Fax: (313) 745-9021
E-mail: vforeman@dmc.org

Goals of the Fellowship Program
The Interventional Cardiology Fellowship Program encompasses the special knowledge and skill required of cardiologists to care for patients receiving cardiac interventional procedures.

During training in interventional cardiology, the Fellow's clinical experience includes opportunities to diagnose, select therapies, perform interventional procedures, and manage and judge the effectiveness of treatment(s) for inpatients and outpatients with chronic coronary artery disease, acute coronary syndromes, valvular heart disease, and peripheral and carotid arterial disease.

As a subspecialty educational program in interventional cardiology, the section functions as an integral component of an accredited subspecialty residency in cardiovascular disease and is organized to provide training and experience at a sufficient level for the fellow to acquire the competency of a specialist in the field.

Interested candidates should contact the office directly.
 

Cindy Grines, M.D., F.A.C.C., SCAI
Vice President, Quality and Academic Affairs

DMC Heart Hospital

Dr. Cindy Grines is an international leader in cardiology, her insights, innovation, and overall impact on acute myocardial infarction and interventional cardiology are truly remarkable. She held the position of Director of the Interventional Cardiology Fellowship Program and Vice Chief for Academic Affairs and was a Professor of Medicine at Oakland University/William Beaumont Hospital. In 2011, after this, she became Vice President of Academic & Clinical Affairs at Detroit Medical Center Heart Hospital.

Dr. Grines has had a significant impact on a number of areas of cardiology and interventional cardiology but in particular with acute myocardial infarction. She is one of the true pioneers of primary percutaneous coronary intervention which had dramatically improved the outcome for patients with STEMI. She has published over 400 peer-reviewed papers or book chapters many of which are landmark papers in the field of interventional cardiology. Dr. Grines is one of the premier interventional cardiology clinical researchers in not only the United States, but the world.

Dr. Grines has also been a remarkable leader for both cardiology and interventional cardiology, playing key roles inthe American College of Cardiology, the Society of Coronary Angiography and Interventions, the American Heart Association, as well as the FDA and NHLBI. She is nationally and internationally respected and has participated in a large number of guidelines/consensus documents/position papers which provide guidance for our current therapies in interventional cardiology.

View Dr. Grines full CV.
 

Theodore L. Schreiber, M.D., F.A.C.C.

Theodore L. Schreiber, M.D., is the President of the DMC Cardiovascular Institute at the Detroit Medical Center in Detroit, Michigan, USA. Additionally, he is the Specialist-in-Chief of Cardiovascular Medicine, a Professor of Medicine at Wayne State University School of Medicine and Clinical Director of Cardiology for the Detroit Medical Center.  As of July 1, 2015 he has been appointed Chief for the Division of Cardiology.  Dr. Schreiber also oversees the Interventional Cardiology Fellowship Program at Harper University Hospital as the Director and has mentored hundreds of young physicians and medical students whose interest is in the field of cardiology.

A graduate of Cornell Medical School in New York, Dr. Schreiber received his cardiology and interventional cardiology training at Cornell Medical Center and William Beaumont Hospital, respectively.

Dr. Schreiber’s areas of special expertise are circulatory support for high risk intervention and transcatheter valve therapies. He has published extensively and has been the Principal Investigator in numerous clinical studies, the most recent being Medtronic’s CoreValve Worldwide Clinical Study.